“What an honor to be asked to share my thoughts regarding the endpoint landscape and diversity goals for clinical trial enrollment with the SOCRA. Change takes time and cooperation and we at Thalocan Research Innovations actively support the companies and organizations working toward better patient outcomes for all people.”
Eric Zudak, CEO – Thalocan Research Innovations